Corgenix Medical Corporation Announces New Automated Hyaluronic Acid (HA) Test Kit at MEDICA 2011

DENVER & DUSSELDORF, GERMANY--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC BB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, announced today the launch of its new Hyaluronic Acid (HA) Immmunoturbidimetric Test Kit for use on automated chemistry analyzers. The announcement was made in Dusseldorf, Germany, at MEDICA 2011, the world’s largest medical industry trade fair, where the product is being exhibited to medical professionals from around the world.

MORE ON THIS TOPIC